Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Afekta Technologies is a Finnish metabolomics service company specializing in high-resolution metabolic profiling for the life sciences, nutrition, and healthcare sectors. The company utilizes advanced non-targeted metabolomics and bioinformatics to identify thousands of small molecules in biological samples, providing insights into metabolic pathways and biomarker discovery. Their services support drug development, clinical research, and the food industry by characterizing the physiological effects of interventions. As a spin-off from the University of Eastern Finland, Afekta combines academic expertise with commercial analytical services. The company's platform enables a holistic view of the metabolome, helping clients understand the complex interactions between diet, gut microbiota, and host health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Afekta.